Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 16
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does human behavior affect endangered African painted dog behavior?

    Highly social with individuals that care for sick, injured, and elderly pack members, African painted dogs are...

    It's all about the attitude: personality, fitness, and foraging in northern elephant seals

    Studies on marine mammal personalities are scarce, despite research showing that personality can relate to foraging...

    Backer Badge Funded